Sleep Apnea, Obstructive Clinical Trial
— OMTAOSAOfficial title:
The Effect of Orofacial Myofunctional Therapy With Autofeedback and the Effect of Anatomical and Behavioral Variables on Adherence to Orofacial Myofunctional Therapy in Patients With Mild or Moderate Obstructive Sleep Apnea
The overall aim of this study is to estimate the effect of orofacial myofunctional therapy (OMT) plus auto-monitoring compared to auto-monitoring alone. Moreover, the investigators aim to identify anatomical and behavioural predictors of OMT adherence
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 31, 2025 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients referred to Ahus or the Fertilitas clinic - A diagnosis of obstructive sleep apnea according to the current International Classsification of Sleep Disorders (ICSD) version 3 criteria {Berry, 2020, The AASM Manual for the Scoring of Sleep and Associated Events: Rules', Terminology and Technical Specifications', Version 2.6.;, 2014, International classification of sleep disorders', 3rd ed.}, with a respiratory event index (REI) <30. - Not previously or currently treated with PAP or MAD - Signed informed, written consent. - Owning a mobile phone with software compatible for the study application Age =18 year. - Body mass index <30 - Ability to breathe through the nose - Ability to read and willingness to follow the protocol as described in the written consent form - Teeth 5-to 5 should be present or fixed by prosthesis or implants. - No botulinium toxin in facial muscles last three months Exclusion Criteria: - Failure to fill in at least 70% of days in the electronic sleep diary provided in the mobile app for two weeks. - Medical or psychiatric conditions which may interfere with the study protocol in the opinion of the investigator. Examples are acute psychosis, drug abuse and dementia. This will be noted in the study inclusion-exclusion document for each approached candidate for the study. The information will then be discussed in an exlusion committee consisting of dr. Skirbekk, Jagomägi, Dammen and Hrubos-Strøm. - Tongue-tie as described below. Participants with mouth opening of <50% with the tip of the tongue at the incisive papilla compared to total mouth opening will be excluded. |
Country | Name | City | State |
---|---|---|---|
Estonia | Fertilitas clinic | Tallinn | |
Norway | Akershus University Hospital | Lørenskog | Akershus |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Akershus | Oslo Metropolitan University, Reykjavik University, University of Oslo, University of Tartu |
Estonia, Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Apnea hypopnea index reduction | Measured by self-applied somnography. The index represents number of apneas or hypopneas per hour from 0/h. Higher values represents more severe disease. | 3 months | |
Secondary | Change in the Epworth Sleepines scale | The scale is a validated tool measuring sleepiness between 0-24. Higher values represent more sleepiness | 3 months | |
Secondary | Orofacial myofunctional therapy adherence | Measured by application registration between 1-3 per day. Three exercises per day is the maximum score | 3 months | |
Secondary | Change in desaturation severity parameter measured by medical device | Measured by photoplethysmography obtained by self-applied somnography. More severity represents more disease. | 3 months | |
Secondary | Change in desaturation duration measured by medical device | Measured by photoplethysmography obtained by self-applied somnography. Longer duration represents more disease. | 3 months | |
Secondary | Change in objective sleep quality | Measured by self-applied somnography. Sleep quality is the ratio between total sleep time and time in bed. A higher ratio is better. | 3 months | |
Secondary | Change in desaturation severity parameter measured by wearable | Measured by photoplethytsmography obtained by Withings Scan Watch. More severity represents more disease. | 3 months | |
Secondary | Change in desaturation duration measured by wearable | Measured by photoplethytsmography obtained by Withings Scan Watch. Longer duration represents more disease. | 3 months | |
Secondary | Change in stroop test | Measured by Flexibility game in application. More correct answers is better | 3 months | |
Secondary | Change in reaction test | Measured by reaction game in application. Shorter reaction time is better | 3 months | |
Secondary | Change in memory test | Measured by memory game in application. Longer sequences memorized is better | 3 months | |
Secondary | Change in perception test | Measured by perception game in application. More correct answers is better. | 3 months | |
Secondary | Change general health status | Measured by a visual analogue scale in the BEAMER questionnaire, two visio analogue scales on general health and 3 items on acceptance and control scored 1-6 respectively. | 3 months | |
Secondary | Changes in the Orofacial Myofunctional Evaluation with Scores | Measured by scorer blinded for randomization. Range 37-103. A lower score represents more dysfunction. | 3 months | |
Secondary | Changes in tongue strength | Objective strength measured by the Iowa Oral Pressure Inventory. A higher score represents more strenght. | 3 months | |
Secondary | Changes in tongue endurance | Objective endurance measured by the Iowa Oral Pressure Inventory. A higher score represents more endurance. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03605329 -
Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS
|
N/A | |
Completed |
NCT04912635 -
Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo
|
N/A | |
Not yet recruiting |
NCT05939934 -
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
|
N/A | |
Enrolling by invitation |
NCT02290236 -
Monitored Saturation Post-ICU
|
N/A | |
Completed |
NCT02088723 -
Testing the Elevation as Sleep Apnea Treatment
|
N/A | |
Terminated |
NCT02269774 -
Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT02261857 -
3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea
|
Early Phase 1 | |
Completed |
NCT01181570 -
Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
|
Phase 4 | |
Completed |
NCT01943708 -
Novel Auto-continuous Positive Airway Pressure (CPAP) Validation
|
Phase 3 | |
Completed |
NCT00273754 -
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
|
Phase 2 | |
Recruiting |
NCT02166879 -
Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
|
||
Recruiting |
NCT04963192 -
Integrated Management of Chronic Respiratory Diseases
|
N/A | |
Completed |
NCT04846400 -
Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia
|
N/A | |
Completed |
NCT05056766 -
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
|
||
Recruiting |
NCT04314492 -
Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults
|
N/A | |
Completed |
NCT05175287 -
OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association
|
||
Active, not recruiting |
NCT03431038 -
Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH
|
N/A | |
Enrolling by invitation |
NCT03075787 -
Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03300037 -
HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor
|
N/A | |
Recruiting |
NCT06097949 -
AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy
|